Proactive, innovative and persistent young man who is looking in the future and working as Backed Developer. Proactive, innovative and persistent young man who is looking in the future and working as ...

BRANCHBURG, N.J., March 10, 2026 /PRNewswire/ --Clordisys, headquartered in Branchburg, New Jersey, announces the publication of Chlorine Dioxide Medical Device Sterilization: Residual Toxicity ...

I'm a Data Analyst, researcher and statistics enthusiast. This story contains new, firsthand information uncovered by the writer. Story's Credibility AI-assisted This story contains AI-generated text.

The Python extension now supports multi-project workspaces, where each Python project within a workspace gets its own test tree and Python environment. This document explains how multi-project testing ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...

NEW YORK – The minimal residual disease testing market continued to grow in 2025 as the biomarker based on the detection and analysis of circulating tumor DNA becomes increasingly clinically validated ...

MRD testing is underutilized in clinical practice due to uncertainty in its impact on patient management decisions. The MIDAS trial suggests omitting ASCT in multiple myeloma patients achieving ...

Table: Global Residual DNA Testing Market (by Region), $Billion, 2024-2035 Figure: Global Residual DNA Testing Market (by Offering), $Billion, 2024 and 2035 Figure ...

Minimal residual disease (MRD) testing—using circulating tumor DNA (ctDNA) to detect minute traces of cancer after treatment—is generating increased interest in the management of solid tumors. As ...

Minimal Residual Disease (MRD) testing is transforming how doctors detect, track, and treat cancer. What is minimal residual disease? It refers to the tiny number of cancer cells that remain after ...